Flagship Global Health amends warrants

By LLuvia Mares

New York, Sept. 12 - Flagship Global Health, Inc. announced Wednesday that it amended the warrants from its July private placement.

As modified on Sept. 6, the warrants and are not exercisable until a year from the closing date of July 16. The warrants expire in four years. Originally they were immediately exercisable and ran for three years.

Flagship originally priced the $14.98 million offering of 6,809,258 shares of common stock and warrants to purchase 2,042,777 shares of common stock at an exercise price of $3.00 per share in July.

The group of investors included FrontPoint Healthcare Fund, LP, FrontPoint Healthcare Fund 2X, LP, FrontPoint Healthcare Horizons Fund, LP and FrontPoint Healthcare Long Horizons Fund, LP.

New York-based Flagship Global Health is an international health assurance organization that provides patient advocacy and emergency support resources.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.